Related Experiment Video
Updated: Dec 29, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming
Yang Liu1,2, Li-Li Lu1, Duo Wen1,3
1Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Background:
MicroRNA-612 (miR-612) has been proven to suppress EMT, stemness, and tumor metastasis of hepatocellular carcinoma (HCC) via PI3K/AKT2 and Sp1/Nanog signaling. However, its biological roles on HCC progression are far from elucidated.
Methods:
We found direct downstream target of miR-612, hadha by RNA immunoprecipitation and sequencing. To explore its biological characteristic, potential molecular mechanism, and clinical relevance in HCC patients, we performed several in-vitro and in-vivo models, as well as human tissue chip.
Results:
Ectopic expression of miR-612 could partially reverse the level of HADHA, then suppress function of pseudopods, and diminish metastatic and invasive potential of HCC by lipid reprogramming. In detail, miR-612 might reduce invadopodia formation via HADHA-mediated cell membrane cholesterol alteration and accompanied with the inhibition of Wnt/β-catenin regulated EMT occurrence. Our results showed that the maximum oxygen consumption rates (OCR) of HCCLM3miR-612-OE and HCCLM3hadha-KD cells were decreased nearly by 40% and 60% of their counterparts (p < 0.05). The levels of acetyl CoA were significantly decreased, about 1/3 (p > 0.05) or 1/2 (p < 0.05) of their controls, in exogenous miR-612 or hadha-shRNA transfected HCCLM3 cell lines. Besides, overexpression of hadha cell lines had a high expression level of total cholesterol, especially 27-hydroxycholesterol (p < 0.005). SREBP2 protein expression level as well as its downstream targets, HMGCS1, HMGCR, MVD, SQLE were all deregulated by HADHA. Meanwhile, the ATP levels were reduced to 1/2 and 1/4 in HCCLM3miR-612-OE (p < 0.05) and HCCLM3hadha-KD (p < 0.01) respectively. Moreover, patients with low miR-612 levels and high HADHA levels had a poor prognosis with shorter overall survival.
Conclusion:
miR-612 can suppress the formation of invadopodia, EMT, and HCC metastasis and by HADHA-mediated lipid programming, which may provide a new insight of miR-612 on tumor metastasis and progression.
Insights
MicroRNA-612 (miR-612) suppresses hepatocellular carcinoma (HCC) progression by targeting HADHA, reprogramming lipids, and inhibiting metastasis. Low miR-612 and high HADHA levels correlate with poor patient prognosis, highlighting miR-612 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNA-612 (miR-612) is known to inhibit epithelial-mesenchymal transition (EMT), stemness, and metastasis in hepatocellular carcinoma (HCC).
- The precise biological roles and molecular mechanisms of miR-612 in HCC progression remain incompletely understood.
Purpose of the Study:
- To elucidate the biological characteristics and clinical relevance of miR-612 in HCC.
- To investigate the molecular mechanisms underlying miR-612's function in HCC progression, focusing on its downstream targets and metabolic reprogramming.
Main Methods:
- RNA immunoprecipitation and sequencing (RIP-seq) to identify direct downstream targets of miR-612.
- In vitro and in vivo models, including cell lines and human tissue chips, were used to study HCC progression.
- Analysis of cellular metabolism, including oxygen consumption rates (OCR) and ATP levels, and lipid reprogramming pathways.
Main Results:
- HADHA was identified as a direct downstream target of miR-612.
- miR-612 suppressed HCC cell invasion and metastasis by reprogramming lipids, reducing invadopodia formation, and inhibiting Wnt/β-catenin-mediated EMT via HADHA-mediated cholesterol alteration.
- Metabolic analysis revealed decreased OCR, acetyl CoA, and ATP levels in cells with miR-612 overexpression or HADHA knockdown.
- High HADHA and low miR-612 expression in HCC patients correlated with poor overall survival.
Conclusions:
- miR-612 suppresses invadopodia formation, EMT, and HCC metastasis through HADHA-mediated lipid reprogramming.
- These findings offer novel insights into the role of miR-612 in regulating tumor progression and metastasis in HCC.
- miR-612 and HADHA represent potential biomarkers and therapeutic targets for HCC.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:47Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Related Concept Videos
Cancer Cell Migration through Invadopodia
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway